Medium Chain(미디엄 체인)란 무엇입니까?
Medium Chain 미디엄 체인 - Results showed that the thickness of amorphous lamellae was mainly correlated with the amount of amylose short and medium chains. [1] High filling temperature decreased significantly head milled rice rate, setback, amylose content and the proportion of the short chain of amylopectin, and increased obviously chalkiness, breakdown, gelatinization temperature, gelatinization enthalpy, and the proportion of the medium chain of amylopectin. [2]결과는 무정형 라멜라의 두께가 주로 아밀로스 단쇄 및 중쇄의 양과 상관관계가 있음을 보여주었다. [1] 높은 충전 온도는 도정율, 셋백, 아밀로스 함량 및 아밀로펙틴 단쇄 비율을 유의하게 감소시켰고, 백악질, 분해, 젤라틴화 온도, 젤라틴화 엔탈피 및 아밀로펙틴 중쇄 비율을 명백히 증가시켰다. [2]
short chain fatty 짧은 사슬 지방
The alteration of short chain fatty acids, the accumulation of some medium chain and long chain fatty acids, and decreased markers of lipid peroxidation in the PA samples contrasted with previous research. [1] In contrast, short chain fatty acids (SCFAs) and medium chain fatty acids (MCFAs), the OAs mainly used as antibiotics alternative, act on the pathogens depending on the pKa value. [2] Results showed that the levels of ethyl acetate, acetate higher alcohol esters (AHEs), short chain fatty acid ethyl esters (SFEs), and medium chain fatty acid ethyl esters (MFEs) were significantly enhanced in mixed fermentation. [3] Protective metabolites were enriched in Medium Chain Fatty Acids (MCFAs) and in Short Chain Fatty Acids (SCFAs) and particularly involved odd-numbered and dicarboxylate Fatty Acids. [4] Forty-seven sows and their progeny were used to determine if feeding gestating and lactating sows a Bacillus licheniformis direct-fed microbial (DFM), an organic acid blend of medium chain and short chain fatty acids (OA), or in combination improves sow lactation feed and water intake, litter growth, and subsequent reproductive performance. [5] Altered circulating levels of free fatty acids (FFAs), namely short chain fatty acids (SCFAs), medium chain fatty acids (MCFAs), and long chain fatty acids (LCFAs), are associated with metabolic, gastrointestinal, and malignant diseases. [6]단쇄 지방산의 변경, 일부 중쇄 및 장쇄 지방산의 축적, PA 샘플에서 감소된 지질 과산화 마커는 이전 연구와 대조적입니다. [1] 이에 반해 주로 항생제 대체제로 사용되는 OAs인 단쇄지방산(SCFA)과 중쇄지방산(MCFA)은 pKa 값에 따라 병원체에 작용한다. [2] nan [3] nan [4] nan [5] nan [6]
% w w % W w
Medium chain triglycerides (MCT) oil was gelled using ethylcellulose (EC) at increasing concentration (10, 15, 20% w/w) and grade (EC20, 45, 100), eventually in combination with fillers. [1] The developed CVNE comprised of 5% w/w oily phase (medium chain triglycerides + CV), 2% w/w surfactants (Tween 80®/Span 80®), and 93% w/w water, and was produced by ultrasonication. [2] This study aimed to assess the impact of lipid phase state being liquid or gelled using glyceryl stearate (GS) at 1% (w/w) as well as the hydrophilic emulsifier (T80: Tween 80 or lecithin) and the oil type (MCT:medium chain triglyceride or corn oil (CO) as long chain triglyceride) on the formation and stabilization of chlorophyllin W1/O/W2 emulsions. [3] 53% w/w) when medium chain triglyceride (MCT) oil was used as an oil phase. [4]중쇄 트리글리세리드(MCT) 오일은 증가하는 농도(10, 15, 20% w/w) 및 등급(EC20, 45, 100)에서 에틸셀룰로오스(EC)를 사용하여 최종적으로 충전제와 함께 겔화되었습니다. [1] 개발된 CVNE는 5% w/w 유상(중간 사슬 트리글리세라이드 + CV), 2% w/w 계면활성제(Tween 80®/Span 80®) 및 93% w/w 물로 구성되어 있으며 초음파 처리에 의해 생성되었습니다. [2] nan [3] nan [4]
drug resistant epilepsy 약물 내성 간질
Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy’ by Schoeler et al. [1] One of these diets, the medium chain triglyceride ketogenic diet, involves high fat dietary intake in the form of medium chain fatty acids (MCFAs), decanoic and octanoic acid, and is commonly used in endurance and high intensity exercises but has also demonstrated beneficial effects in the treatment of numerous pathologies including drug resistant epilepsy, cancer, and diabetes. [2] Historically, classic high fat ketogenic diets (KD) and medium chain triglycerides (MCT) KD have been successfully used to manage drug-resistant epilepsy. [3]Vita: 약물 내성 간질을 관리하기 위한 중쇄 트리글리세리드 혼합물의 타당성 연구' by Schoeler et al. [1] 이러한 다이어트 중 하나인 중쇄 트리글리세리드 케톤 생성 다이어트는 중쇄 지방산(MCFA), 데칸산 및 옥탄산 형태의 고지방 식이 섭취를 포함하며 지구력 및 고강도 운동에 일반적으로 사용되지만 유익한 효과도 입증되었습니다 약물 내성 간질, 암 및 당뇨병을 포함한 수많은 병리의 치료에 사용됩니다. [2] nan [3]
dietary intervention consisted 식이 개입 구성
The dietary intervention consisted of a KD supplemented with medium chain triglycerides (MCT). [1] The dietary intervention consisted of a KD supplemented with medium chain triglycerides (MCT). [2] The dietary intervention consisted of a Modified Atkins Diet (ModAD) supplemented with medium chain triglycerides (MCT). [3]식이 개입은 중쇄 트리글리세리드(MCT)가 보충된 KD로 구성되었습니다. [1] 식이 개입은 중쇄 트리글리세리드(MCT)가 보충된 KD로 구성되었습니다. [2] nan [3]
sn glycero 3 sn 글리세로 3
METHODS Cationic nanoemulsions were composed of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(amino[polyethylene glycol]-2000) (DSPE-PEG), 1,2-dioleoyl-sn-glycero-3-trimethylammonium propane (DOTAP), medium chain triglycerides, glycerol, and water and were prepared by high-pressure homogenization and were repeatedly administered to MPS I mice for IDUA production and gene expression. [1] Two candidate lipids were identified, a short chain length phospholipid (1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC)) and a medium chain length lysolipid (1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (16:0 Lyso-PC)). [2]행동 양식 양이온성 나노에멀젼은 1,2-디올레오일-sn-글리세로-3-포스포에탄올아민(DOPE), 1,2-디스테아로일-sn-글리세로-3-포스포에탄올아민-N-(아미노[폴리에틸렌글리콜]-2000)(DSPE- PEG), 1,2-디올레오일-sn-글리세로-3-트리메틸암모늄 프로판(DOTAP), 중쇄 트리글리세리드, 글리세롤 및 물을 고압 균질화하여 제조하고 IDUA 생성 및 유전자를 위해 MPS I 마우스에 반복적으로 투여하였다. 표현. [1] nan [2]
13 di oleic 13 올레익
Cells were treated with vehicle, oleic acid (OA), OA + coconut oil (CO), OA + rapeseed oil (RO), OA + physical mixture oil of CO and RO (CROM), OA + interesterified oil of CO and RO (CROI, rich in medium- and long-chain triglycerides (MLCTs)), OA + 1,3-di-oleic-2-medium chain triglycerides (OMO, a kind of MLCTs) and OA + 1,3-di-oleic-2-palmitic triglyceride (OPO) for 24 h. [1] In the present study, a kind of structured lipids, namely 1,3-di-oleic-2-medium chain (OMO) triacylglycerols, were synthesized through lipase-catalyzed reactions using coconut oil and rapeseed acid as materials in a trace water-in-oil system. [2]세포는 비히클, 올레산(OA), OA+코코넛 오일(CO), OA+유채 기름(RO), OA+CO 및 RO의 물리적 혼합 오일(CROM), OA+CO 및 RO의 인터에스테르화된 오일( CROI, 중쇄 및 장쇄 트리글리세리드(MLCT), OA+1,3-디-올레산-2-중쇄 트리글리세리드(OMO, MLCT의 일종) 및 OA+1,3-디-올레산- 24시간 동안 2-팔미틱 트리글리세리드(OPO). [1] 본 연구에서는 미량의 수분에 코코넛 오일과 유채산을 재료로 사용하여 리파아제 촉매 반응을 통해 구조화된 지질, 즉 1,3-di-oleic-2-medium chain (OMO) 트리아실글리세롤을 합성했습니다. - 오일 시스템. [2]
whey protein isolate 분리 유청 단백질
These formulae were based on whey protein isolate, whey protein isolate + lactoferrin, long chain triacylglycerols or long + medium chain triacylglycerols. [1] Nanoemulsions were formulated using a plant-based oil (medium chain triglycerides, MCT) and either a plant-based (Quillaja saponaria, QS) or animal-based (whey protein isolate, WPI) emulsifier. [2]이 공식은 분리 유청 단백질, 분리 유청 단백질 + 락토페린, 장쇄 트리아실글리세롤 또는 장쇄 + 중쇄 트리아실글리세롤을 기반으로 합니다. [1] 나노에멀젼은 식물성 오일(중쇄 트리글리세리드, MCT)과 식물성(Quillaja saponaria, QS) 또는 동물성(분리유청단백, WPI) 유화제를 사용하여 제형화되었습니다. [2]
% fish oil % 생선 기름
Pigs delivered 7d preterm (n = 59) were randomized to receive different lipid emulsions for 11 days: 100% soybean oil (SO), mixed oil emulsion (SO, medium chain olive oil and fish oil) including 15% fish oil (MO15), or 100% fish oil (FO100). [1] BACKGROUND & AIMS Mixed oil intravenous lipid emulsion (MO ILE) that contains 30% soybean oil (SO), 30% medium chain triglycerides, 25% olive oil and 15% fish oil can benefit hospitalized patients receiving parenteral nutrition (PN) but there are very few studies on its long-term use. [2]7일째 미숙아를 분만한 돼지(n = 59)는 무작위 배정되어 11일 동안 다양한 지질 에멀젼을 받았습니다. , 또는 100% 어유(FO100). [1] 배경 및 목표 30% 대두유(SO), 30% 중쇄 트리글리세리드, 25% 올리브유 및 15% 어유를 함유하는 혼합유 정맥내 지질 유제(MO ILE)는 비경구 영양(PN)을 받는 입원 환자에게 도움이 될 수 있지만 연구는 거의 없습니다. 그것의 장기 사용에. [2]
long chain fatty 긴 사슬 지방
Linseed oil supplementation decreased medium chain fatty acid proportion and n-6/n-3 ratio, conversely it increased long chain fatty acids and n-3 fatty acid content of milk, ether extract intake and total-tract digestibility. [1] Inhibition was also specic for long and very-long chain fatty acids and not for medium chain fatty acids, which are transported by diffusion. [2]아마인유 보충은 중쇄지방산 비율과 n-6/n-3 비율을 감소시켰고, 반대로 우유의 장쇄지방산과 n-3 지방산 함량, 에테르 추출물 섭취 및 전체 소화율을 증가시켰습니다. [1] 억제는 또한 확산에 의해 수송되는 중쇄 지방산이 아닌 장쇄 및 매우 긴 사슬 지방산에 대해 특이했습니다. [2]
Containing Medium Chain 중쇄 함유
The oil blends containing medium chain triacylglycerols also showed adequacy to produce stable emulsions with reduced droplet size (1. [1] In this study, the physicochemical properties and stability of ultrasonic assisted flaxseed protein isolates (FPI) emulsions containing medium chain triglycerides (MCT), soybean oil, flaxseed oil,. [2] Upon diagnosis, baby was discontinued of breast feeding completely and was given a special diet devoid of triglyceride and containing medium chain fatty acid diet and was also started with fenofibrate. [3] Methods: We designed a new-KD with a fat to carbohydrate plus protein ratio of 2:1, containing medium chain triglycerides (MCT), docosahexaenoic acid (DHA), low glycaemic index carbohydrates, fibres and the ketogenic amino acid leucine, and evaluated its neuroprotective potential in adult TBI. [4] Octanoic acid is a medium-chained saturated fatty acid found abundantly in the ketogenic dietary supplements containing medium chained triglycerides (MCT) along with decanoic acid. [5] The aim of this work was the formulation and the comprehensive evaluation of the viscous eye drops using vehicles containing medium chain chitosan (0. [6]중쇄 트리아실글리세롤을 함유한 오일 블렌드는 또한 감소된 액적 크기(1. [1] 이 연구에서 중쇄 트리글리세리드(MCT), 대두유, 아마씨유를 함유하는 초음파 보조 아마씨 단백질 분리물(FPI) 에멀젼의 물리화학적 특성 및 안정성. [2] nan [3] nan [4] nan [5] nan [6]
Dehydrogenase Medium Chain 탈수소효소 중간 사슬
The expression of peroxisomal acyl-coenzyme A oxidase 1 and acyl-CoA dehydrogenase medium chain was also significantly increased, by 1. [1] AST also up‐regulated the expression of phosphorylated AMP‐activated protein kinase, acetyl‐CoA carboxylase, acetyl‐coenzyme A synthetase, carnitine palmitoyltransferase 1a/1b, enoyl coenzyme A hydratase‐short chain, acyl‐CoA dehydrogenase medium chain and mitochondrial 3‐hydroxy‐3‐methylglutaryl‐CoA synthase‐2 involved in fat metabolism. [2] 05), which was regulated by modulating methylation levels in the promoters of acyl-CoA oxidase 1 (ACOX1) and acyl-CoA dehydrogenase medium chain (ACADM). [3]peroxisome acyl-coenzyme A oxidase 1 및 acyl-CoA 탈수소효소 중쇄의 발현도 1만큼 유의하게 증가했습니다. [1] AST는 또한 인산화된 AMP 활성 단백질 키나제, 아세틸-CoA 카르복실라제, 아세틸-코엔자임 A 합성효소, 카르니틴 팔미토일트랜스퍼라제 1a/1b, 에노일 조효소 A 히드라타제-단쇄, 아실-CoA 탈수소효소 중쇄 및 미토콘드리아 3-의 발현을 상향 조절했습니다. hydroxy-3-methylglutaryl-CoA synthase-2는 지방 대사에 관여합니다. [2] nan [3]
Valuable Medium Chain
ethanol, lactate) into more valuable medium chain carboxylates. [1] Microbial chain elongation has been investigated as a process to upgrade diluted ethanol to more valuable medium chain carboxylic acids. [2]에탄올, 젖산염)을 더 가치 있는 중쇄 카복실레이트로 변환합니다. [1] nan [2]
medium chain triglyceride 중쇄 트리글리세리드
The cases received one capsule of 1000 mg omega-3 daily and the controls received one capsule of 1000 mg medium chain triglyceride daily as placebo for eight weeks. [1] The relationship between gel strength and structure on the micro- and nano-scale has been investigated for oleogels prepared in a range of triglyceride (TAG) oils (sunflower, olive, medium chain triglyceride) using mixtures of oleic acid (OA) and sodium oleate (SO) as gelling agents. [2] She was managed initially with nil per oral, parenteral nutrition, medium chain triglyceride (MCT) containing oil and abdominal paracentesis, followed by octreotide. [3] In this study, papaverine eyedrops based on medium chain triglycerides were prepared and the effect of diethyl glycol monoethyl ether (DGME) on their ocular distribution was evaluated using an ex vivo porcine eye model. [4] Cells were treated with vehicle, oleic acid (OA), OA + coconut oil (CO), OA + rapeseed oil (RO), OA + physical mixture oil of CO and RO (CROM), OA + interesterified oil of CO and RO (CROI, rich in medium- and long-chain triglycerides (MLCTs)), OA + 1,3-di-oleic-2-medium chain triglycerides (OMO, a kind of MLCTs) and OA + 1,3-di-oleic-2-palmitic triglyceride (OPO) for 24 h. [5] METHODS: This 6-month interventional study included MCI participants randomized to a placebo (n = 16) or ketogenic medium chain triglyceride (kMCT; n = 17) drink. [6] In this study, the dissolution and crystallization behaviors of PS/PSE mixtures in medium chain triglyceride (MCT) were studied, and the synergistic mechanism of PS/PSE mixtures on the crystallization behaviors of MCT was further clarified. [7] Herein, oil-in-water (O/W) Pickering emulsions were stabilized by autofluorescent gelatin nanoparticles with either corn oil or medium chain triglyceride (MCT) oil as references for commonly studied edible oils. [8] Additionally, she exhibited lack of efficacy during treatment with medium chain triglycerides/soya oil emulsion for local anaesthetic systemic toxicity. [9] PURPOSE The brain can utilise medium chain triglycerides (MCTs) as an alternative fuel than glucose, and research has shown that MCT ingestion improves cognitive function in diseased and/or elderly individuals. [10] Medium chain triglycerides (MCT) oil was gelled using ethylcellulose (EC) at increasing concentration (10, 15, 20% w/w) and grade (EC20, 45, 100), eventually in combination with fillers. [11] 300 Cannabis vaping liquids, including vitamin E acetate, medium chain triglycerides oil (MCT oil), polyethylene glycols, squalane, triethyl citrate, dipropylene glycol dibenzoate (DPG dibenzoate), pine rosin acids, pine rosin methyl esters, and sucrose acetate isobutyrate (SAIB). [12] Oil-in-water excipient emulsions were prepared using different types of oils: corn oil, olive oil, and medium chain triglycerides (MCT). [13] Recent research has shown that metabolic therapies including the ketogenic diet and medium chain triglycerides can improve energy metabolism in the brain. [14] RESULTS The final optimal formulation was medium chain triglyceride: oleic acid: Cremophor RH40: Transcutol HP (w/w) (12%: 12%: 32%: 44%), with a drug loading capacity of 5 mg/g. [15] Non-medical options include a medium chain triglyceride oil enriched diet, and cannabidiol. [16] To increase the palatability medium chain triglycerides (as coconut oil) in ratio of 3:1 is used which is more efficiently absorbed and have lesser gastro intestinal side effects as compared to traditional 4:1 ratio diet with long chain triglycerides like PUFA. [17] 4 ml/kg MCT-oil™ (medium chain triglycerides) or 0. [18] Additionally, he received soya-oil emulsion/medium chain triglyceride/olive oil/fish oil [Smoflipid] as a substitute nutrition source. [19] The effect of a mainly polyunsaturated oil (soybean oil) and a mainly medium chain triglyceride oil (coconut oil) on the absorption of the phenolic antioxidant chlorogenic acid (5-caffeoylquinic acid) was investigated using 90 healthy volunteers. [20] For preterm infants who cannot be fed maternal or donor breast milk or may require supplementation, preterm formulas with fat in the form of medium chain triglycerides (MCTs) or long chain triglycerides (LCTs) may be chosen to support nutrient utilization and to improve growth. [21] We have identified more than 100 terpenes and natural extracts, 19 cannabinoids, and other potential toxic additives such as Vitamin E Acetate, Polyethylene Glycols, and Medium Chain Triglycerides. [22] He was treated with high-protein and low-fat diet, and supplemental formula high in medium chain triglycerides. [23] ME was formulated with α-tocopheryl polyethylene glycol succinate (TPGS) – Span 80 (3:1) as surfactant mixture and Captex 355 (a medium chain triglyceride) as oil phase. [24] The developed CVNE comprised of 5% w/w oily phase (medium chain triglycerides + CV), 2% w/w surfactants (Tween 80®/Span 80®), and 93% w/w water, and was produced by ultrasonication. [25] The dietary intervention consisted of a KD supplemented with medium chain triglycerides (MCT). [26] Diets with a ketogenic profile or the intake of ketogenic supplements (as ketone esters, ketone salts and medium chain triglycerides) have been associated with neuroprotective effects and with positive actions on metabolism, with the potential of delaying the aging process (26). [27] In this study, the physicochemical properties and stability of ultrasonic assisted flaxseed protein isolates (FPI) emulsions containing medium chain triglycerides (MCT), soybean oil, flaxseed oil,. [28] The evidence of effectiveness and safety was explored for nicotinamide adenine dinucleotide, acetyl- l -carnitine, α-ketoglutarate, succinate, creatine and creatine analogs (including creatine phosphate, cyclocreatine, and guanidinoacetic acid), citicoline, medium chain triglycerides, quercetin, resveratrol, coenzyme Q10, and other nutraceuticals, while focusing this analysis to experimental trials in humans. [29] New emulsions comprised of fish oil and medium chain triglycerides show promise for reducing the incidence of PNAC in infants. [30] The dietary intervention consisted of a KD supplemented with medium chain triglycerides (MCT). [31] Propranolol was discontinued and frequent feeding, oral diazoxide, medium chain triglyceride oil, and special milk for glycogen storage disease were administered to alleviate the side effects of propranolol and HH. [32] 250 mg/kg) combined with beta-hydroxybutyrate salt + medium chain triglyceride (KSMCT; 2. [33] Due to the poor stability of calcitriol, a large amount of medium chain triglycerides (>99. [34] Aims and Objectives: To compare efficacy between Propofol Medium Chain Triglycerides-Long ChainTriglycerides and Propofol Long Chain Triglycerides with lidocaine pretreatment under venous occlusionon propofol induced pain. [35] The cooperativity of six cations (Ca2+, Mg2+, Zn2+, Al3+, Cr3+ and Fe3+), three pectins (sugar beet, high and low methyl esterified), three dispersed phases (medium chain triglycerides (MCT), orange oil and hexadecane), time (30 days) and pH (2. [36] Optimized formulations contained 6% lipid (85% solid lipid (Cetostearyl alcohol and glyceryl behenate) and 15% oil either medium chain triglycerides or isopropyl myristate) stabilized by 2% polysorbate 80 and 0. [37] In order to explore the mechanism further, glyceryl trioleate (GLT) and medium chain triglycerides (MCT) with similar structures were added and compared. [38] The dietary intervention consisted of a Modified Atkins Diet (ModAD) supplemented with medium chain triglycerides (MCT). [39] Very high drug loads (>40% related to lipid content) could be achieved in emulsions of medium chain triglycerides, rapeseed oil, soybean oil and trimyristin. [40] One hundred ‘Green Fairy’ samples have been analysed to determine the cannabinoid content, including 12 fully extracted cannabis oil (FECO) samples, 12 ethanolic tinctures, 6 vape juices, 39 oily liquids with olive oil, hemp seed oil, or medium chain triglycerides (MCT) as a base, and 31 waxy solids made using coconut oil. [41] LN with different medium chain triglycerides (MCT) concentrations were prepared by ultrasonic method. [42] Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy’ by Schoeler et al. [43] BACKGROUND & AIMS Mixed oil intravenous lipid emulsion (MO ILE) that contains 30% soybean oil (SO), 30% medium chain triglycerides, 25% olive oil and 15% fish oil can benefit hospitalized patients receiving parenteral nutrition (PN) but there are very few studies on its long-term use. [44] Suggestions to use carnitine and medium chain triglycerides remain controversial; conversely, other potential dietary supplements able to sustain muscle metabolism and recovery from exercise have never been taken into consideration. [45] Medium chain triglycerides (MCT) are important substrates of the energy metabolism and anabolic processes in mammals. [46] One of these diets, the medium chain triglyceride ketogenic diet, involves high fat dietary intake in the form of medium chain fatty acids (MCFAs), decanoic and octanoic acid, and is commonly used in endurance and high intensity exercises but has also demonstrated beneficial effects in the treatment of numerous pathologies including drug resistant epilepsy, cancer, and diabetes. [47] Nanoemulsions were formulated using a plant-based oil (medium chain triglycerides, MCT) and either a plant-based (Quillaja saponaria, QS) or animal-based (whey protein isolate, WPI) emulsifier. [48] In this study, multilayer coatings were formed from saponins, polypeptides, and polysaccharides using medium chain triglyceride (MCT) lipid droplets as templates (pH 4. [49] Over time, KDTs themselves have undergone various modifications to improve tolerability and clinical feasibility, including the Modified Atkins diet (MAD), medium chain triglyceride (MCT) diet and the low glycaemic index treatment (LGIT). [50]사례는 매일 1000mg 오메가-3 캡슐 1개를 받았고 대조군은 8주 동안 위약으로 매일 1000mg 중쇄 트리글리세리드 캡슐 1개를 받았습니다. [1] 올레산(OA)과 올레산나트륨의 혼합물을 사용하여 다양한 트리글리세리드(TAG) 오일(해바라기, 올리브, 중쇄 트리글리세리드)에서 제조된 올레오겔에 대해 마이크로 및 나노 규모의 겔 강도와 구조 간의 관계가 조사되었습니다. (SO) 겔화제. [2] 그녀는 처음에 경구, 비경구 영양, 기름을 함유한 중쇄 트리글리세리드(MCT) 및 복부 천자를 사용하여 관리한 후 옥트레오타이드로 관리했습니다. [3] 이 연구에서는 중쇄 트리글리세리드를 기반으로 하는 파파베린 점안액을 제조하고 생체 외 돼지 눈 모델을 사용하여 안구 분포에 대한 DGME(디에틸 글리콜 모노에틸 에테르)의 효과를 평가했습니다. [4] 세포는 비히클, 올레산(OA), OA+코코넛 오일(CO), OA+유채 기름(RO), OA+CO 및 RO의 물리적 혼합 오일(CROM), OA+CO 및 RO의 인터에스테르화된 오일( CROI, 중쇄 및 장쇄 트리글리세리드(MLCT), OA+1,3-디-올레산-2-중쇄 트리글리세리드(OMO, MLCT의 일종) 및 OA+1,3-디-올레산- 24시간 동안 2-팔미틱 트리글리세리드(OPO). [5] nan [6] 이에 연구, PS/PSE 혼합물의 용해 및 결정화 거동 중쇄 트리글리세리드(MCT)의 시너지 효과를 연구했습니다. MCT의 결정화 거동에 대한 PS/PSE 혼합물의 메커니즘은 추가로 명확히 했습니다. [7] 여기에서, 수중유(O/W) 피커링 에멀젼은 일반적으로 연구되는 식용유에 대한 참조로서 옥수수유 또는 중쇄 트리글리세리드(MCT) 오일과 함께 자가형광 젤라틴 나노입자에 의해 안정화되었습니다. [8] 또한, 그녀는 국소 마취 전신 독성에 대한 중쇄 트리글리세리드/대두 오일 에멀젼으로 치료하는 동안 효능이 부족함을 나타냈습니다. [9] nan [10] 중쇄 트리글리세리드(MCT) 오일은 증가하는 농도(10, 15, 20% w/w) 및 등급(EC20, 45, 100)에서 에틸셀룰로오스(EC)를 사용하여 최종적으로 충전제와 함께 겔화되었습니다. [11] 비타민 E 아세테이트, 중쇄 트리글리세리드 오일(MCT 오일), 폴리에틸렌 글리콜, 스쿠알란, 트리에틸 시트레이트, 디프로필렌 글리콜 디벤조에이트(DPG 디벤조에이트), 파인 로진 산, 파인 로진 메틸 에스테르 및 수크로스 아세테이트 이소부티레이트(SAIB)를 포함한 300 대마초 베이핑 액체 ). [12] 수중유 부형제 에멀젼은 옥수수 오일, 올리브 오일 및 중쇄 트리글리세리드(MCT)와 같은 다양한 유형의 오일을 사용하여 제조되었습니다. [13] 최근 연구에 따르면 케톤 생성 식단과 중쇄 트리글리세리드를 포함한 대사 요법이 뇌의 에너지 대사를 개선할 수 있습니다. [14] 결과 최종 최적 제형은 중쇄 트리글리세리드: 올레산: Cremophor RH40: Transcutol HP(w/w)(12%: 12%: 32%: 44%)였으며, 약물 로딩 용량은 5 mg/g이었습니다. [15] 비의료 옵션에는 중쇄 트리글리세리드 오일이 풍부한 식단과 칸나비디올이 포함됩니다. [16] nan [17] 4 ml/kg MCT-oil™(중쇄 트리글리세리드) 또는 0. [18] 또한 대체 영양 공급원으로 대두유 유제/중쇄 트리글리세리드/올리브유/어유[스모피피드]를 받았습니다. [19] nan [20] 산모 또는 기증 모유를 먹일 수 없거나 보충이 필요할 수 있는 조산아의 경우, 영양 이용을 지원하고 성장을 개선하기 위해 중쇄 트리글리세리드(MCT) 또는 장쇄 트리글리세리드(LCT) 형태의 지방이 포함된 조산 조제분유를 선택할 수 있습니다. [21] 우리는 100가지 이상의 테르펜 및 천연 추출물, 19가지 칸나비노이드 및 비타민 E 아세테이트, 폴리에틸렌 글리콜, 중쇄 트리글리세리드와 같은 기타 잠재적인 독성 첨가제를 확인했습니다. [22] 그는 고단백 및 저지방 식이요법과 중쇄 트리글리세리드가 많이 함유된 보충제로 치료를 받았습니다. [23] ME는 α-토코페릴 폴리에틸렌 글리콜 숙시네이트(TPGS) – Span 80(3:1)을 계면활성제 혼합물로 사용하고 Captex 355(중쇄 트리글리세리드)를 오일상으로 사용하여 ME를 제조했습니다. [24] 개발된 CVNE는 5% w/w 유상(중간 사슬 트리글리세라이드 + CV), 2% w/w 계면활성제(Tween 80®/Span 80®) 및 93% w/w 물로 구성되어 있으며 초음파 처리에 의해 생성되었습니다. [25] 식이 개입은 중쇄 트리글리세리드(MCT)가 보충된 KD로 구성되었습니다. [26] nan [27] 이 연구에서 중쇄 트리글리세리드(MCT), 대두유, 아마씨유를 함유하는 초음파 보조 아마씨 단백질 분리물(FPI) 에멀젼의 물리화학적 특성 및 안정성. [28] nan [29] nan [30] 식이 개입은 중쇄 트리글리세리드(MCT)가 보충된 KD로 구성되었습니다. [31] nan [32] nan [33] nan [34] nan [35] nan [36] nan [37] nan [38] nan [39] nan [40] nan [41] nan [42] Vita: 약물 내성 간질을 관리하기 위한 중쇄 트리글리세리드 혼합물의 타당성 연구' by Schoeler et al. [43] 배경 및 목표 30% 대두유(SO), 30% 중쇄 트리글리세리드, 25% 올리브유 및 15% 어유를 함유하는 혼합유 정맥내 지질 유제(MO ILE)는 비경구 영양(PN)을 받는 입원 환자에게 도움이 될 수 있지만 연구는 거의 없습니다. 그것의 장기 사용에. [44] nan [45] nan [46] 이러한 다이어트 중 하나인 중쇄 트리글리세리드 케톤 생성 다이어트는 중쇄 지방산(MCFA), 데칸산 및 옥탄산 형태의 고지방 식이 섭취를 포함하며 지구력 및 고강도 운동에 일반적으로 사용되지만 유익한 효과도 입증되었습니다 약물 내성 간질, 암 및 당뇨병을 포함한 수많은 병리의 치료에 사용됩니다. [47] 나노에멀젼은 식물성 오일(중쇄 트리글리세리드, MCT)과 식물성(Quillaja saponaria, QS) 또는 동물성(분리유청단백, WPI) 유화제를 사용하여 제형화되었습니다. [48] nan [49] nan [50]
medium chain fatty 중간 사슬 지방
The purpose of this review is to describe the medium chain fatty acids present in vegetable oils absorption mechanism and their benefits for human body, combined with technological advantages in the preparation of food formulations. [1] The aim of this review is to comprehensively discuss the current state of the art and prospects of medium chain fatty acids (MCFAs) production in MES from CO2 and waste organics. [2] 001) and short and medium chain fatty acids (P < 0. [3] In addition, goat milk has specific fat composition of the medium chain fatty acids led to increase the antioxidant and antibacterial and anticancer properties. [4] In contrast, short chain fatty acids (SCFAs) and medium chain fatty acids (MCFAs), the OAs mainly used as antibiotics alternative, act on the pathogens depending on the pKa value. [5] The two modified BSF larvae fats had a high and low ratio of monobutyrin to monoglycerides of medium chain fatty acid, respectively. [6] The conversion of organic wastes/wastewater into medium chain fatty acids (MCFAs) such as caproate has attracted much attention, while the effects of toxic compounds on the process have rarely been studied. [7] A total of 38 mixed parity sows were used from 28-d of gestation until weaning to determine the effects of medium chain fatty acids (MCFA) in sow and nursery pig diets on litter characteristics and growth performance. [8] Medium chain fatty acids (MCFA) amount was 4. [9] Treatments groups were Control (C) without acidifier, combination of inorganic acid/ organic acids (T1), combinations of organic acids (T2), combination of organic acids and essential oil (T3), combination of organic acids and medium chain fatty acids (T4) and double salted organic acid (T5). [10] Among these alternatives, medium chain fatty acids (MCFAs) or organic acids (OAs) are considered to be suitable for in-feed use. [11] The lipase exhibited a degree of adaptability in various organic solvents and metal ions, and showed high specificity towards triglycerides with short and medium chain fatty acids. [12] However, the characteristics of slightly longer 6 to 10 carbon, medium chain fatty acids (MCFA), derived primarily from diet, are less understood. [13] In a circular economy strategy, waste resources can be used for the biological production of high added-value substances, such as medium chain fatty acids (MCFAs), thus minimising waste and favouring a sustainable process. [14] Here, we employed the medium chain fatty acid caprate, a biologically safe, clinically applicable substance, to modulate tight junctions of the RWM. [15] Results showed that the levels of ethyl acetate, acetate higher alcohol esters (AHEs), short chain fatty acid ethyl esters (SFEs), and medium chain fatty acid ethyl esters (MFEs) were significantly enhanced in mixed fermentation. [16] Introduction: Virgin Coconut Oil (VCO) contains a lot of medium chain fatty acids. [17] Virgin Coconut Oil (VCO) contains a lot of medium chain fatty acids, combined with coffee grounds (Coffea Arabica Linn. [18] Metabolomic analysis on flies in which bmm is downregulated reveals a marked reduction in medium chain fatty acids, long chain saturated fatty acids and long chain monounsaturated and polyunsaturated fatty acids, and an increase in diacylglycerol levels. [19] The main objective of this research was to evaluate the effect of curcumin (Curcuma longa) nanoemulsions, using mono- and diacylglycerides medium chain fatty acids as stabilizers in an in vivo hepatic steatosis rat model. [20] Ghrelin is a multifunctional gut peptide with a unique structure, which is modified by a medium chain fatty acid at the third serine by ghrelin O-acyl transferase (GOAT). [21] We detected changes consistent with enhanced fatty acid oxidation in INT relative to placebo, especially a decrease in medium chain fatty acids, their carnitinylates, and a decrease in bilirubin degradation byproducts. [22] Metabolomic analysis on flies in which bmm is downregulated reveals a marked reduction in medium chain fatty acids, long chain saturated fatty acids and long chain monounsaturated and polyunsaturated fatty acids, and an increase in diacylglycerol levels. [23] Protective metabolites were enriched in Medium Chain Fatty Acids (MCFAs) and in Short Chain Fatty Acids (SCFAs) and particularly involved odd-numbered and dicarboxylate Fatty Acids. [24] 1% combination of C8, C10 and C12 medium chain fatty acids (MCFA), and 5) 20% modified oats (MO). [25] Linseed oil supplementation decreased medium chain fatty acid proportion and n-6/n-3 ratio, conversely it increased long chain fatty acids and n-3 fatty acid content of milk, ether extract intake and total-tract digestibility. [26] Upon diagnosis, baby was discontinued of breast feeding completely and was given a special diet devoid of triglyceride and containing medium chain fatty acid diet and was also started with fenofibrate. [27] Litsea cubeba (LC) kernel is a kind of waste after LC essential oil processing, which oil was found to be rich in medium chain fatty acids. [28] The aim of this study was to evaluate the effect of two typical yeast preparation (ADY and YC) supplementation on the concentration of ruminal medium chain fatty acid, lactic acid, ethanol and the abundance of relative rumen bacteria in finishing beef cattle. [29] AIMS This research tested the anti-Campylobacter properties of organic acids (OA), medium chain fatty acids (MCFA), and essential oils (EO) in vitro and commenced in vivo suitability testing focused on broiler performance. [30] Reduction in seizures or paroxysmal events correlated significantly with blood concentrations of medium chain fatty acids (C10 and C8) but not ß-hydroxybutyrate. [31] Altered circulating levels of free fatty acids (FFAs), namely short chain fatty acids (SCFAs), medium chain fatty acids (MCFAs), and long chain fatty acids (LCFAs), are associated with metabolic, gastrointestinal, and malignant diseases. [32] Medium chain fatty acids (MCFAs) that produced from affordable waste biomass via chain elongation (CE) technology are recognized as the potential alternatives to part fossil-derived chemicals, contributing to the sustainable development of economy and environment. [33] The patient was initially managed conservatively using head end elevation, use of stool softeners, medium chain fatty acid diet and octreotide therapy. [34] While attempting to explore potential alternative, medium chain fatty acid (MCFA) can be used due to its unique nutritional, physiological and antimicrobial property. [35] Therefore, the objective of this study was to evaluate the efficacy of a commercially available formaldehyde-based feed additive, medium chain fatty acid blend (MCFA), and commercially available fatty acid-based products for mitigation of porcine epidemic diarrhea virus (PEDV) and porcine reproductive and respiratory syndrome virus (PRRSV) in a feed matrix. [36] In this paper, the definition, source, physicochemical properties, metabolic characteristics, biological functions, safety and application in nutrition-related fields of medium chain fatty acids will be reviewed and discussed. [37] It is a medium chain fatty acid found naturally in palm kernel oil, coconut oil, and some dairy products. [38] To counter these complicated effects, there are nutritional strategies (including formulation of key amino acids, vitamins, short and medium chain fatty acids, prebiotics, enzymes, among others) that can be utilized to reduce the infection, alleviate the signs, and boost the compensatory growth after infection. [39] Inhibition was also specic for long and very-long chain fatty acids and not for medium chain fatty acids, which are transported by diffusion. [40] Virgin Coconut Oil (VCO) contains a lot of medium chain fatty acids, combined with coffee grounds (Coffea Arabica Linn. [41] 50% medium chain fatty acids blend (MCFA; 1:1:1 ratio of C6:C8:C10, Sigma Aldrich, St. [42] The fatty acid composition of rhinoceros milk is characteristic with a high saturated fatty acids content of 62%-84%, of which the medium chain fatty acids form the major portion. [43] 061 g/kg, and those of medium chain fatty acids (MCFA) were C8 0. [44] In addition, a slight increase in short/medium chain fatty acid ester content was observed. [45] The main purpose of this work was to review the effect of short and medium chain fatty acids, as precursors to inhibit the symptoms of coronavirus. [46] oeni, for instance medium chain fatty acids, as a result of the fermentation with this non-Saccharomyces. [47] Alternative products to formaldehyde, including carboxylic acids, essential oils, and medium chain fatty acids (MCFAs), have exhibited mixed efficacy against PEDv and require application rates higher than formaldehyde. [48] 5 g/kg/day, combination (soy, medium chain fatty acid, olive and fish oil) lipid emulsion, or fish oil-based lipid emulsion. [49] The medium chain fatty acids (MCFAs) produced from organic wastes can replace part fossil-fuel-based products to promote the sustainable development of economy and environment. [50]이 리뷰의 목적은 식물성 기름 흡수 메커니즘에 존재하는 중쇄 지방산과 인체에 대한 이점과 식품 제제 준비의 기술적 이점을 설명하는 것입니다. [1] 이 검토의 목적은 CO2 및 폐기물 유기물로부터 MES의 중쇄 지방산(MCFA) 생산의 현재 상태와 전망을 종합적으로 논의하는 것입니다. [2] 001) 및 단쇄 및 중쇄 지방산(P < 0. [3] 또한, 산양유는 중쇄 지방산의 특정 지방 구성을 가지고 있어 항산화 및 항균 및 항암 특성을 증가시킵니다. [4] 이에 반해 주로 항생제 대체제로 사용되는 OAs인 단쇄지방산(SCFA)과 중쇄지방산(MCFA)은 pKa 값에 따라 병원체에 작용한다. [5] 2종의 변형된 BSF 유충 지방은 각각 중쇄 지방산의 모노글리세라이드에 대한 모노부티린의 비율이 높고 낮았다. [6] 유기 폐기물/폐수를 카프로에이트와 같은 중쇄지방산(MCFA)으로 전환하는 것은 많은 관심을 끌었지만 독성 화합물이 공정에 미치는 영향은 거의 연구되지 않았습니다. [7] 총 38마리의 혼합산산 모돈을 임신 28일부터 이유할 때까지 사용하여 새끼 돼지의 특성과 성장 성능에 대한 암퇘지 및 종묘사료의 중쇄지방산(MCFA) 효과를 확인했습니다. [8] 중쇄지방산(MCFA) 양은 4였다. [9] 처리군은 산성화제가 없는 대조군(C), 무기산/유기산의 조합(T1), 유기산의 조합(T2), 유기산과 에센셜 오일의 조합(T3), 유기산과 중쇄 지방산의 조합( T4) 및 이중염 유기산(T5). [10] 이러한 대안 중에서 중쇄지방산(MCFA) 또는 유기산(OA)이 사료 내 사용에 적합한 것으로 간주됩니다. [11] 리파아제는 다양한 유기용매와 금속이온에서 어느 정도 적응성을 보였고, 단쇄 및 중쇄 지방산을 가진 트리글리세리드에 대해 높은 특이성을 보였다. [12] 그러나 주로 식단에서 파생되는 약간 더 긴 6~10개의 탄소, 중쇄 지방산(MCFA)의 특성은 덜 이해되고 있습니다. [13] 순환 경제 전략에서 폐기물 자원은 중쇄 지방산(MCFA)과 같은 고부가가치 물질의 생물학적 생산에 사용될 수 있으므로 폐기물을 최소화하고 지속 가능한 공정을 선호합니다. [14] 여기서 우리는 생물학적으로 안전하고 임상적으로 적용 가능한 물질인 중쇄 지방산 카프레이트를 사용하여 RWM의 밀착 접합을 조절합니다. [15] nan [16] 소개: 버진 코코넛 오일(VCO)에는 중쇄 지방산이 많이 포함되어 있습니다. [17] 버진 코코넛 오일(VCO)에는 커피 찌꺼기와 결합된 중쇄 지방산이 많이 포함되어 있습니다(Coffea Arabica Linn. [18] bmm가 하향조절되는 파리에 대한 대사체 분석은 중쇄 지방산, 장쇄 포화 지방산 및 장쇄 단일불포화 및 다중불포화 지방산의 현저한 감소와 디아실글리세롤 수준의 증가를 나타냅니다. [19] nan [20] nan [21] nan [22] nan [23] nan [24] nan [25] 아마인유 보충은 중쇄지방산 비율과 n-6/n-3 비율을 감소시켰고, 반대로 우유의 장쇄지방산과 n-3 지방산 함량, 에테르 추출물 섭취 및 전체 소화율을 증가시켰습니다. [26] nan [27] nan [28] nan [29] nan [30] nan [31] nan [32] nan [33] nan [34] nan [35] nan [36] nan [37] nan [38] nan [39] 억제는 또한 확산에 의해 수송되는 중쇄 지방산이 아닌 장쇄 및 매우 긴 사슬 지방산에 대해 특이했습니다. [40] nan [41] nan [42] nan [43] nan [44] nan [45] nan [46] nan [47] nan [48] nan [49] nan [50]
medium chain length 중간 체인 길이
The modelling and optimization of a process for the production of the medium chain length polyhydroxyalkanoate (mcl-PHA) by the bacterium Pseudomonas putida KT2440 when fed a synthetic fatty acid mixture (SFAM) was investigated. [1] A novel generation of gels based on medium chain length poly(3-hydroxyalkanoate)s, mcl-PHAs, were developed by using ionic interactions. [2] GPR84 is a poorly characterized, nominally orphan, proinflammatory G protein-coupled receptor that can be activated by medium chain length fatty acids. [3] Medium chain length polyhydroxyalkanoates (mcl-PHA) were used to formulate both polyenes (Nys and AmB) in the form of films (~50 µm). [4] The sugars obtained from hydrolysis of raw and hot water-pretreated BSG were fermented using a recombinant Escherichia coli LSBJ harboring genes for biosynthesis of either homopolymer polyhydroxybutyrate (PHB) or PHB-co-medium chain length copolymer (PHB-co-MCL). [5] Here, we report a novel blend of a natural medium chain length polyhydroxyalkanoate (MCL-PHA) with a synthetic aliphatic polyester, poly(ε-caprolactone) (PCL), suitable for extrusion-based high-throughput manufacturing. [6] It produces and stores in its seeds medium chain length fatty acids, which currently are derived commercially from seeds of tropical pa Cuphea seeds contain more than 30% of oil rich in medium lauric, and myristic fatty acids (C8:0 In this paper, we through the light on Cuphea seed oils as the only naturally cultivated seed oils that contain the most prominent Medium MCTs oils are trended in the last 20 years as the healthier dietary oil which is essentially nontoxic, noncarcinogenic, and nonmutagenic for human consumption. [7] PHAs are classified as short chain length (3–5 carbon monomers), medium chain length (6–14 carbon monomers), and long chain length (15–18 carbon monomers), depending on the number of carbons in the monomeric constituents. [8] Anaerobic microbial communities can produce carboxylic acids of medium chain length (e. [9] Ether‐linked lipids containing an alkyl moiety with a medium chain length (C11–C14) were uniquely upregulated, and the administration of their biosynthetic precursor 1‐O‐dodecyl‐rac‐glycerol attenuated phorbol 12‐myristate 13‐acetate (PMA) induced vascular cell adhesion molecule‐1 (VCAM‐1) expression. [10] % and a medium chain length PHA, and mcl-PHA, mainly composed of 3-hydroxydecanoate, were studied as scaffolding material for cell culture. [11] Expanding the use of tropical biomass wastes for nitrogen-limited fermentation was investigated, specifically, the production of medium chain length polyhydroxyalkanoates. [12] To date, the only S-domain-RLK from Arabidopsis thaliana with a known ligand and function is AtLORE, a pattern recognition receptor that senses bacterial 3-hydroxy fatty acids of medium chain length, such as 3-hydroxy decanoic acid (3-OH-C10:0), to activate pattern-triggered immunity. [13] The objective of the current study was to develop a high cell density bioreactor-based process for the production of medium chain length polyhydroxyalkanoate (mclPHA) with waste cooking oil as the sole carbon and energy source. [14] Two candidate lipids were identified, a short chain length phospholipid (1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC)) and a medium chain length lysolipid (1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (16:0 Lyso-PC)). [15]합성 지방산 혼합물(SFAM)을 먹였을 때 박테리아 Pseudomonas putida KT2440에 의한 중간 사슬 길이의 폴리하이드록시알카노에이트(mcl-PHA) 생산을 위한 프로세스의 모델링 및 최적화가 조사되었습니다. [1] 중간 사슬 길이의 폴리(3-하이드록시알카노에이트), mcl-PHA를 기반으로 하는 새로운 세대의 겔은 이온 상호작용을 사용하여 개발되었습니다. [2] GPR84는 중간 사슬 길이의 지방산에 의해 활성화될 수 있는 제대로 특성화되지 않은 명목상 고아의 전염증성 G 단백질 결합 수용체입니다. [3] 중간 사슬 길이의 폴리하이드록시알카노에이트(mcl-PHA)를 사용하여 두 폴리엔(Nys 및 AmB)을 필름(~50μm) 형태로 공식화했습니다. [4] 미가공 및 온수 전처리된 BSG의 가수분해로부터 얻은 당은 단일중합체 폴리하이드록시부티레이트(PHB) 또는 PHB-공중쇄 길이 공중합체(PHB-co-MCL)의 생합성을 위한 유전자를 보유하는 재조합 대장균 LSBJ를 사용하여 발효되었습니다. [5] nan [6] nan [7] nan [8] nan [9] nan [10] nan [11] nan [12] nan [13] nan [14] nan [15]
medium chain acyl 중간 사슬 아실
Medium chain acyl-CoA dehydrogenase deficiency (MCADD) is an autosomal recessive fatty acid β-oxidation defect. [1] Metabolomics revealed an acute increase in lactate, citrate, purines, urea, dopamine, eicosanoids, microbiome metabolites, oxidized glutathione, thiamine, niacinamide, and pyridoxic acid, and decreased folate-methylation-1-carbon intermediates, amino acids, short and medium chain acyl-carnitines, phospholipids, ceramides, sphingomyelins, cholesterol, bile acids, and vitamin D similar to some children with ASD. [2] Clinical and molecular aspects of Japanese children with medium chain acyl-CoA dehydrogenase deficiency. [3] Medium chain acyl-CoA dehydrogenase deficiency (MCADD) is a rare metabolic disorder, and commonly now part of newborn screening programs. [4] In this study, we report that estrogens induce the expression of GCN5L1 via GPER agonism in cardiac cells, which increases the enzymatic activity and acetylation status of the fatty acid oxidation enzyme medium chain acyl-CoA dehydrogenase (MCAD). [5] Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD/MTPD) and medium chain acyl-CoA dehydrogenase deficiency (MCADD) were included in the expanded neonatal screening program (ENBS) in Czechia in 2009, allowing for the presymptomatic diagnosis and nutritional management of these patients. [6] Furthermore, silybin reduced lipid accumulation via activating PPARα, inducing the expression of liver cytosolic fatty acid-binding protein, carnitine palmitoyltransferase (Cpt)-1a, Cpt-2, medium chain acyl-CoA dehydrogenase and stearoyl-CoA desaturase-1, and suppressing fatty acid synthase and acetyl-CoA carboxylase α. [7] In France, newborn screening (NBS) program for IEM, limited to phenylketonuria for decades, has been recently extended to medium chain acyl-CoA dehydrogenase deficiency. [8] It has recently been shown that the membranes of certain yeast species contain high levels of unusual asymmetric phospholipids, consisting of one long and one medium chain acyl moiety - a configuration not common in mammalian cells or other well studied model yeast species. [9]중쇄 아실-CoA 탈수소효소 결핍증(MCADD)은 상염색체 열성 지방산 β-산화 결함입니다. [1] 대사체학은 젖산, 구연산염, 퓨린, 요소, 도파민, 에이코사노이드, 미생물군유전체 대사산물, 산화된 글루타티온, 티아민, 나이아신아미드, 피리독신산의 급격한 증가와 감소된 엽산-메틸화-1-탄소 중간체, 아미노산, 단쇄 및 중쇄를 나타냈습니다. 아실-카르니틴, 인지질, 세라마이드, 스핑고미엘린, 콜레스테롤, 담즙산 및 비타민 D는 ASD가 있는 일부 어린이와 유사합니다. [2] 중쇄 아실-CoA 탈수소효소 결핍증이 있는 일본 어린이의 임상 및 분자 측면. [3] 중쇄 아실-CoA 탈수소효소 결핍증(MCADD)은 희귀 대사 장애이며 현재 일반적으로 신생아 선별 프로그램의 일부입니다. [4] nan [5] nan [6] nan [7] nan [8] nan [9]
medium chain carboxylic 중쇄 카르복시산
Bioproduction of medium chain carboxylic acids has recently emerged as an alternative strategy to valorize low-value organic waste and side-streams. [1] Microbial chain elongation enables the conversion of organic wastes and agroindustrial sidestreams into medium chain carboxylic acids (MCCAs), with application in the production of plasticizers, personal care products, functional feed additives, and fuels. [2] Microbial chain elongation has been investigated as a process to upgrade diluted ethanol to more valuable medium chain carboxylic acids. [3] A particular set of anaerobic pathways in MMC fermentation, known as chain elongation, can occur under specific conditions producing medium chain carboxylic acids (MCCAs) with higher value than biogas and broader applicability. [4]중쇄 카르복실산의 생물생산은 최근 가치가 낮은 유기 폐기물 및 부류를 평가하기 위한 대안 전략으로 등장했습니다. [1] 미생물 사슬 연장은 가소제, 퍼스널 케어 제품, 기능성 사료 첨가제 및 연료의 생산에 적용하여 유기 폐기물 및 농업 산업 측류를 중쇄 카르복실산(MCCA)으로 전환할 수 있습니다. [2] nan [3] nan [4]
medium chain triacylglycerol 중쇄 트리아실글리세롤
The oil blends containing medium chain triacylglycerols also showed adequacy to produce stable emulsions with reduced droplet size (1. [1] These formulae were based on whey protein isolate, whey protein isolate + lactoferrin, long chain triacylglycerols or long + medium chain triacylglycerols. [2] The present study investigates oxidative stability using the Rancimat and the Schaal oven test of blends of various edible oils with medium chain triacylglycerols containing natural antioxidants extracted from moringa leaves and pomegranate peel. [3] Reactivity of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical in methanol, ethanol, isopropanol, isooctane, and ethyl acetate, was evaluated to assess the antioxidant capabilities in medium chain triacylglycerol. [4]중쇄 트리아실글리세롤을 함유한 오일 블렌드는 또한 감소된 액적 크기(1. [1] 이 공식은 분리 유청 단백질, 분리 유청 단백질 + 락토페린, 장쇄 트리아실글리세롤 또는 장쇄 + 중쇄 트리아실글리세롤을 기반으로 합니다. [2] nan [3] nan [4]
medium chain saturated 중간 사슬 포화
Expression of selected genes responsible for lipid metabolism showed similar trends in medium chain saturated and long chain polyunsaturated diet groups. [1] Several unsaturated FAs were increased while short and medium chain saturated FAs were decreased by linseed treatment. [2] Coconut oil (CO) is enriched with medium chain saturated fatty acids like lauric acid (LA), capric acid and caprylic acid, which are known to have several health benefits. [3]지질 대사를 담당하는 선택된 유전자의 발현은 중쇄 포화 및 장쇄 다중불포화 식이군에서 유사한 경향을 보였다. [1] 아마씨 처리에 의해 단쇄 및 중쇄 포화 FA가 감소한 반면 여러 불포화 FA가 증가했습니다. [2] nan [3]
medium chain carboxylate 중쇄 카복실레이트
ethanol, lactate) into more valuable medium chain carboxylates. [1] Ammonium accumulation is inevitable during the fermentation of food waste (FW), challenging the application of chain elongation process upgrading FW into the high-value biochemical n-caproate, which is a medium chain carboxylate. [2] Chain elongation produce medium chain carboxylates, which are important precursors to many pharmaceuticals, antimicrobials and biofuels. [3]에탄올, 젖산염)을 더 가치 있는 중쇄 카복실레이트로 변환합니다. [1] 암모늄 축적은 음식물 쓰레기(FW)의 발효 중에 불가피하며, FW를 중쇄 카르복실레이트인 고가의 생화학적 n-카프로에이트로 업그레이드하는 사슬 연장 공정의 적용에 도전합니다. [2] nan [3]
medium chain fa 미디엄 체인 파
Discriminants of the P40 group were TG and PC containing in their backbone saturated medium chain FA thus suggesting greater de novo fatty synthesis in the mammary gland. [1] Co-expressing UcFatB and CnLPAT produced up to 17 mol% accumulation of lauric acid (12:0) in seed TAGs, whereas CvFatB1 CvLPAT2 CpDGAT1 combinatorial expression produced up to 27 mol% medium chain FAs Medium Chain Fatty Acids mostly in the form of capric acid (10:0). [2]P40 그룹의 판별자는 백본에 포화된 중쇄 FA를 함유하는 TG 및 PC로 유선에서 더 큰 새로운 지방 합성을 시사합니다. [1] UcFatB와 CnLPAT를 공동 발현하면 종자 TAG에서 최대 17 mol%의 라우르산 축적(12:0)을 생성한 반면, CvFatB1 CvLPAT2 CpDGAT1 조합 발현은 최대 27 mol% 중쇄 FA 생성 중쇄 지방산을 대부분 카프르산 형태로 생성 산(10:0). [2]
medium chain acylcarnitine 중쇄 아실카르니틴
Placental profiles of NNRTI-treated WLHIV exhibited lower levels of amino acids, including essential and branched-chain amino acids, and some medium chain acylcarnitines. [1] In untargeted metabolomics, LV MI, EDV, and ESV were also associated with higher levels of short-medium chain acylcarnitines and histamine metabolites, and lower levels of tryptophan metabolites via the indole pathway (all FDR Disclosure M. [2]NNRTI로 처리된 WLHIV의 태반 프로필은 필수 및 분지쇄 아미노산과 일부 중쇄 아실카르니틴을 포함한 아미노산 수준이 더 낮은 것으로 나타났습니다. [1] 비표적 대사체학에서 LV MI, EDV 및 ESV는 또한 인돌 경로를 통한 더 높은 수준의 단쇄 아실카르니틴 및 히스타민 대사 산물 및 더 낮은 수준의 트립토판 대사 산물과 관련이 있었습니다(모든 FDR 공개 M. [2]